Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sapindus trifoliatus extract is a plant-derived preparation obtained from the fruit pericarp of Sapindus trifoliatus, a species in the Sapindaceae family, commonly referred to as Indian soapberry or Washnut[3][6][7][8]. The extract contains a rich mixture of triterpenoid saponins (notably hederagenin) and is traditionally used for both medicinal and cosmetic purposes. Pharmacologically, it has demonstrated **anti-inflammatory**, **analgesic**, **antimigraine**, **anticonvulsant**, **anti-helmintic**, **antibacterial**, and **antifungal** effects[3][4][6]. Its central nervous system activity includes potential neuroleptic and hepatoprotective properties, and it has been investigated for both migraine prophylaxis and seizure management[1][4]. Mechanistically, Sapindus trifoliatus extract exhibits receptor binding affinity towards multiple CNS targets, notably **dopaminergic, alpha-adrenergic, muscarinic, GABA-A agonist site, Glutamate-AMPA, Glutamate-Kainate, Glutamate-NMDA agonist and glycine sites**, and **Sodium channel (site 2)**[1][4]. Traditional indications include migraine, epilepsy, fever, inflammation, bronchial asthma, cough, and skin disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sapindus trifoliatus extract.